Podcasts

What breakthroughs are redefining multiple myeloma treatment and patient outcomes?

Listen to experts, Klaus Schmierer, Tarunya Arun, Mavis Ayer, and Joela Mathews explore what the label expansion of cladribine tablets…

In this series, host Saranya Ravindran speaks with Holly Wyatt about the evolving landscape of obesity treatment in the era of glucagon-like peptide-1 (GLP-1) medications.

Diabetic Peripheral Neuropathy affects millions worldwide, yet it remains one of the most underdiagnosed and undertreated complications…

What does the future hold for genitourinary cancer care? Viktor Grünwald dives into precision medicine breakthroughs and reveals his vision for achieving more cures in oncology.

From identifying viral versus bacterial infections, to optimising antibiotic use in meningitis and exploring the future of vaccines, this series provides actionable insights into safeguarding children’s health worldwide.

In this special World Mental Health Day episode, Jonathan speaks with Debi Roberts about breaking down barriers to mental health conversations and creating practical pathways for suicide prevention.

How is the field of hematology evolving? In this episode, Dr. Gupta explores groundbreaking innovations from stem cell donation to the use of artificial intelligence in advancing blood science and patient care.

Step into the world of modern osteopathy with Sandy Phanor in this podcast series. From busting myths in a quickfire Q&A to exploring the emotional side of healing, Phanor shares real-world insights from the clinic.

In this episode, Claudio Cerchione recaps the 2025 International Myeloma Society (IMS) Annual Meeting, highlighting key advances in treatment, the evolving research landscape, and more.

In this first episode of the EMJ podcast series, independent health communications specialist Sue Saville is joined by renowned…

This podcast, supported by an unconditional educational grant from Chiesi Farmaceutici S.p.A., who were not involved in its creation…

In this series, host Jonathan Sackier speaks with Jed Beitler about the evolution of healthcare communications and its impact on global health.

How is scientific innovation is transforming the latest in lung cancer research and care. Chair of the Medical Oncology Department at Hospital Universitario, Luis Paz-Ares, talks about from prevention to emerging treatments in lung cancer.

Rohan Jotwani, anesthesiologist and XR/AI innovator, shares how immersive technology is transforming pain management, medical training, and more

Catherine Glass chats with Rob Pieters, Professor of Pediatric Oncology and co-founder of the Princess Máxima Center, Europe’s largest childhood cancer center.

This expert-led podcast explores healthcare sustainability in the face of climate change, highlighting how guideline-directed…

Gonzalo Pérez Marc, paediatrician and clinical researcher, shares insights from the BERNI study on maternal RSV vaccination and strategies to protect infants worldwide.

Refractory Chronic Cough (RCC) is more than just a lingering symptom; it’s a misunderstood condition that disrupts lives…

Sara Tolaney shares insights on breast cancer care, including her research on CDK4/6 inhibitors and exploring ways to de-escalate treatment.

Explore the dual challenge of alcohol use disorder and liver disease in this series with Stephanie Rutledge.

Friedreich’s ataxia (FA) is a rare genetic disease that can affect children and adults and cause progressive neurodegeneration, loss of…

What are myeloproliferative neoplasms, and what can research reveal about future therapies? Andrew Dunbar explores the biology, resistance, and emerging treatment strategies.

In the first instalment of our Paediatric Infectious Diseases series, host Saranya Ravindran is joined by Debby Bogaert, world-renowned paediatric infectious disease expert, to explore the infant respiratory microbiome and its role in health and disease.

In the third episode of our Rare Lung Diseases podcast series,, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases.

How is the breast cancer landscape evolving, from HER2-low breakthroughs to the future of targeted therapy and precision care?

Catherine Glass sits down with leading diabetes researcher Vinod Patel to discuss the future of Type 2 diabetes care, exploring new technologies, predictive tools, retinal imaging, and much more.

Emanuele Angelucci shares the latest on cellular therapies, gene therapy, and breakthroughs in treating haemoglobinopathies.

In this deeply personal episode, Jonathan Sackier speaks with Zoe Strickland, author of To Grief With Love, about how she navigated the loss of her son and found space for healing through creative expression and connection.

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Explore the evolving role of methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led podcast featuring leading…

What is the link between pain and anxiety? David Cosio, Clinical Psychologist, Interdisciplinary Pain Program, Jesse Brown VA Medical, Chicago, Illinois, USA, shares the latest advances in pain management and more.

Stephen Freedland explores how lifestyle, equity, and emerging therapeutics are reshaping prostate cancer care, from risk to survivorship.

In the second episode of our Rare Lung Diseases podcast series, discover the complexities of pulmonary arterial hypertension with Neal Chaisson, Assistant Professor of Medicine at the Cleveland Clinic.

Steven Okoli, Honorary Senior Clinical Lecturer at Imperial College London, shares how AI, advocacy, and stem cell trials are driving the next chapter in sickle cell care.

In the first episode of our Rare Lung Diseases podcast series, host Saranya Ravindran speaks with James Stoller, Cleveland Clinic, about Alpha-1 antitrypsin deficiency, a rare genetic condition that is frequently underdiagnosed.

In this episode Jonathan is joined by Jean Abraham, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.

Claudio Cerchione explores advances in multiple myeloma, MRD, and CAR-T therapy, with key insights from EHA and ASCO in this Hema Now episode.

In this three-part series, Jonathan Sackier sits down with Professor Zoë Paskins to explore the complexities and advancements in rheumatology and bone health.

In this podcast, Kenneth Alexander and Jorg Schelling, experts in the fields of infectious disease and family medicine, respectively…

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes (MDS), and their implications for future care.

Discover the growing impact of environmental factors on men’s health – from the risks of microplastics to the benefits of plant-based diets, and much more

In the third episode of our lung cancer series, Jonathan Sackier is joined by Douglas E. Wood to explore the critical role of lung cancer staging, the evolution of screening guidelines, and more.

Lennard Lee, Associate Professor of Cancer Vaccines at the University of Oxford, shares how large-scale collaboration is shaping the future of cancer vaccines and oncology innovation.

Lydia Scarfò discusses types of leukaemia, current treatment approaches, recent advances, and future possibilities.

This week, the host Saranya Ravindran welcomes Tommaso Falcone, reproductive health pioneer and global healthcare leader. From redefining…

In this second episode of our lung cancer podcast series, Jonathan Sackier is joined by David Baldwin, a leading expert in lung cancer screening, epidemiology, and policy.

Podcast series on Becker Muscular Dystrophy (BMD), exploring diagnosis, disease progression, treatment and…

Bradley Monk, Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists, shares key understandings from the Society of Gynecologic Oncology (SGO) 2025, alongside a fascinating deep dive into drug approval and access.

In the third episode of our Infectious Disease Diagnostics series, Jonathan sits down with global diagnostics leader Rosanna Peeling to explore the life-saving role of diagnostics in global health, sexually transmitted diseases, and COVID-19.

Rafael Fonseca, Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA

Kicking off a special podcast series on lung cancer, Jonathan Sackier is joined by Haval Balata, Consultant Respiratory Physician at Manchester University NHS Foundation Trust, to explore pioneering early detection efforts, public misconceptions, and innovations reshaping lung cancer screening and diagnosis.

Bradley Monk, Medical Director of Late-Phase Research at Florida Cancer Specialists, shares his insights from ESGO 2025 and landmark studies in gynaecologic oncology.

In this bonus episode, join EMJ host Dr Hannah Moir as she speaks with our two health and wellbeing experts, Dr Sula Windgassen and Kiera McGarrity, who provide their expertise and personal experiences of using intermittent catheters.

Paolo Gallipoli, Clinical Reader, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London joins the podcast to discuss the biology, onset, and treatment of myeloid leukaemias.

  In this series, Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA, discusses the importance of hope in patient care and the inspiration behind starting her own practice.